These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 28377431)

  • 41. Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.
    Yoshimura M; Yasue H; Tanaka H; Kikuta K; Sumida H; Kato H; Jougasaki M; Nakao K
    Br Heart J; 1994 Dec; 72(6):528-33. PubMed ID: 7857734
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The natriuretic peptide system in the brain: implications in the central control of cardiovascular and neuroendocrine functions.
    Imura H; Nakao K; Itoh H
    Front Neuroendocrinol; 1992 Jul; 13(3):217-49. PubMed ID: 1334000
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers.
    Gwechenberger M; Huelsmann M; Graf S; Berger R; Bonderman D; Stanek B; Rauscha F; Pacher R
    Eur J Clin Invest; 2004 Dec; 34(12):811-7. PubMed ID: 15606723
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sacubitril/valsartan: beyond natriuretic peptides.
    Singh JSS; Burrell LM; Cherif M; Squire IB; Clark AL; Lang CC
    Heart; 2017 Oct; 103(20):1569-1577. PubMed ID: 28689178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sacubitril/Valsartan (LCZ696) in Heart Failure.
    Khder Y; Shi V; McMurray JJV; Lefkowitz MP
    Handb Exp Pharmacol; 2017; 243():133-165. PubMed ID: 28004291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure.
    Tsutamoto T; Wada A; Maeda K; Hisanaga T; Fukai D; Maeda Y; Ohnishi M; Mabuchi N; Kinoshita M
    Am Heart J; 1997 Nov; 134(5 Pt 1):910-6. PubMed ID: 9398103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monitoring B-type natriuretic peptide in patients undergoing therapy with neprilysin inhibitors. An emerging challenge?
    Lippi G; Sanchis-Gomar F
    Int J Cardiol; 2016 Sep; 219():111-4. PubMed ID: 27317994
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Responses of cardiac natriuretic peptides after paroxysmal supraventricular tachycardia: ANP surges faster than BNP and CNP.
    Kuo JY; Wang AM; Chang SH; Hung CL; Chen CY; Shih BF; Yeh HI
    Am J Physiol Heart Circ Physiol; 2016 Mar; 310(6):H725-31. PubMed ID: 26801306
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent advances in natriuretic peptides in congestive heart failure.
    Boerrigter G; Burnett JC
    Expert Opin Investig Drugs; 2004 Jun; 13(6):643-52. PubMed ID: 15174950
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP.
    Rosenkranz AC; Woods RL; Dusting GJ; Ritchie RH
    Cardiovasc Res; 2003 Feb; 57(2):515-22. PubMed ID: 12566124
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure.
    Rademaker MT; Charles CJ; Kosoglou T; Protter AA; Espiner EA; Nicholls MG; Richards AM
    Am J Physiol; 1997 Nov; 273(5):H2372-9. PubMed ID: 9374774
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Natriuretic peptide system: physiology and clinical utility.
    Suttner SW; Boldt J
    Curr Opin Crit Care; 2004 Oct; 10(5):336-41. PubMed ID: 15385748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Natriuretic peptide system].
    Itoh H; Nakao K
    Nihon Rinsho; 1997 Aug; 55(8):1923-36. PubMed ID: 9284403
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Haemodynamic, hormonal and renal actions of osteocrin in normal sheep.
    Scott NJA; Prickett TCR; Charles CJ; Espiner EA; Richards AM; Rademaker MT
    Exp Physiol; 2024 Aug; 109(8):1305-1316. PubMed ID: 38890799
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Natriuretic peptide family].
    Nakao K
    Nihon Naibunpi Gakkai Zasshi; 1992 Mar; 68(3):134-42. PubMed ID: 1349867
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular biology and biochemistry of natriuretic peptide family.
    Ogawa Y; Itoh H; Nakao K
    Clin Exp Pharmacol Physiol; 1995 Jan; 22(1):49-53. PubMed ID: 7768034
    [TBL] [Abstract][Full Text] [Related]  

  • 57. BNP and NT-proBNP Interpretation in the Neprilysin Inhibitor Era.
    Sbolli M; deFilippi C
    Curr Cardiol Rep; 2020 Sep; 22(11):150. PubMed ID: 32951154
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Depressed Corin Levels Indicate Early Systolic Dysfunction Before Increases of Atrial Natriuretic Peptide/B-Type Natriuretic Peptide and Heart Failure Development.
    Tripathi R; Wang D; Sullivan R; Fan TH; Gladysheva IP; Reed GL
    Hypertension; 2016 Feb; 67(2):362-7. PubMed ID: 26667411
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LCZ696 (Valsartan/Sacubitril)--A Possible New Treatment for Hypertension and Heart Failure.
    Andersen MB; Simonsen U; Wehland M; Pietsch J; Grimm D
    Basic Clin Pharmacol Toxicol; 2016 Jan; 118(1):14-22. PubMed ID: 26280447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), C-type natriuretic peptide (CNP)].
    Tsujino M; Hirata Y
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():577-80. PubMed ID: 16149581
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.